SEC Form 4 · accession 0001014108-15-000110
XZERES Corp. · XPWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Debruce
10% Owner
Period of report
Apr 6, 2015
Accepted (ET)
Apr 7, 2015 · 10:42 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001084597
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.001 per share | Apr 6, 2015 | P | 3,967,000 | $0.15 | A | 15,219,672 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1,F2 | $0.2344 | holding | — | — | — | Jul 31, 2013 | Jul 31, 2017 | Common Stock | 976,658 | 976,658 | D |
| Warrants (right to buy)F1,F3 | $0.2539 | holding | — | — | — | Oct 1, 2013 | Oct 1, 2017 | Common Stock | 687,047 | 687,047 | D |
| Warrants (right to buy)F1,F4 | $0.3062 | holding | — | — | — | Dec 16, 2013 | Dec 16, 2016 | Common Stock | 2,794,256 | 2,794,256 | D |
| Warrants (right to buy)F1,F5 | $0.2963 | holding | — | — | — | Apr 23, 2014 | Apr 23, 2018 | Common Stock | 1,144,984 | 1,144,984 | D |
Explanation of responses
- F1The number of shares to which these warrants relate, as well as their respective exercise prices, are subject to antidilution adjustment provisions.
- F2This warrant is exercisable for such number of shares as equals 1.03459% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $228,951, and previously was reported as relating to 829,246 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 976,658 shares of Common Stock upon payment of an aggregate exercise price of $228,951 ($0.2344 per share), subject to further adjustment under the warrant's antidilution provisions.
- F3This warrant is exercisable for such number of shares as equals 0.7278% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $174,417, and previously was reported as relating to 583,347 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 687,047 shares of Common Stock upon payment of an aggregate exercise price of $174,417 ($0.2539 per share), subject to further adjustment under the warrant's antidilution provisions.
- F4This warrant is exercisable for such number of shares as equals 2.96% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $855,555, and previously was reported as relating to 2,372,503 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 2,794,256 shares of Common Stock upon payment of an aggregate exercise price of $855,555 ($0.3062 per share), subject to further adjustment under the warrant's antidilution provisions.
- F5This warrant is exercisable for such number of shares as equals 1.2129% of the fully diluted outstanding shares of Common Stock upon payment of an aggregate exercise price of $339,206, and previously was reported as relating to 972,165 shares. After giving effect to the warrant's antidilution provisions, as of April 3, 2015, the warrant is exercisable for a total of 1,144,984 shares of Common Stock upon payment of an aggregate exercise price of $339,206 ($0.2963 per share), subject to further adjustment under the warrant's antidilution provisions.